Legal Investigation Into Semler Scientific: Investors Urged to Act Amid Claims
Faruqi & Faruqi, LLP, a distinguished national securities law firm, has initiated an investigation into the possible claims involving Semler Scientific, Inc. This inquiry comes in light of allegations that Semler may have breached federal securities laws. The firm is urging any investors who have incurred losses related to Semler Scientific during the period from March 10, 2021, to April 15, 2025, to reach out to them for further discussions regarding their legal rights.
The firm’s Securities Litigation Partner, James (Josh) Wilson, has emphasized the importance of this outreach, stating that it could help investors understand their options. This follows the firm’s notification to Semler Scientific investors that they must act promptly, as the deadline to nominate a lead plaintiff in the federal securities class action suit has been set for October 28, 2025.
The core of the allegations against Semler Scientific is rooted in their failure to adequately disclose a significant investigation conducted by the United States Department of Justice (DOJ) concerning potential violations of the False Claims Act. It has come to attention that, rather than clarifying the situation, Semler’s statements regarding compliance and DOJ enforcement were misleading and those misrepresentations have been ongoing.
This investigation stems from a recent development when Semler disclosed in its 2024 annual report, filed with the Securities and Exchange Commission (SEC), that it had begun initial discussions for a settlement with the DOJ on February 11, 2025. However, those discussions ceased on the same day. As a result, the firm has raised concerns about the possibility of the DOJ pursuing a civil lawsuit under the False Claims Act, asserting that the severity of potential damages cannot be reasonably estimated.
On February 28, 2025, the company released this pivotal information, leading to a sharp decline of over 9% in their stock price during the following trading day. Given this volatility, it is becoming increasingly critical for affected investors to understand their situation and participate in the ongoing legal proceedings.
The court will appoint a lead plaintiff who holds the largest financial stake in the case, and this individual will have the responsibility of managing the litigation on behalf of the affected class members. However, it's important to note that participating as a lead plaintiff is not compulsory. Any impacted investor retains their right to recovery regardless of whether they choose to take on this active role or remain a member of the class.
Faruqi & Faruqi, LLP promotes engagement with anyone who might possess information regarding the actions of Semler Scientific. This includes former employees, whistleblowers, and shareholders who can provide insights into the company’s practices during the investigated timeframe.
For those interested in understanding more about the class action concerning Semler Scientific, the firm has created a dedicated page with comprehensive details. Interested parties are encouraged to visit it or contact Josh Wilson for personal consultations to evaluate their potential claims further.
Through its commitment to safeguarding the rights of investors, Faruqi & Faruqi aims to ensure that the facts surrounding Semler Scientific's operations are brought to light and addressed appropriately. With its long-standing history of recovering substantial sums for clients since its establishment in 1995, the firm emphasizes its dedication to providing quality legal support to its clients. Investors must act swiftly to navigate this complex legal environment effectively, ensuring they are heard and their rights are upheld.
The firm’s Securities Litigation Partner, James (Josh) Wilson, has emphasized the importance of this outreach, stating that it could help investors understand their options. This follows the firm’s notification to Semler Scientific investors that they must act promptly, as the deadline to nominate a lead plaintiff in the federal securities class action suit has been set for October 28, 2025.
The core of the allegations against Semler Scientific is rooted in their failure to adequately disclose a significant investigation conducted by the United States Department of Justice (DOJ) concerning potential violations of the False Claims Act. It has come to attention that, rather than clarifying the situation, Semler’s statements regarding compliance and DOJ enforcement were misleading and those misrepresentations have been ongoing.
This investigation stems from a recent development when Semler disclosed in its 2024 annual report, filed with the Securities and Exchange Commission (SEC), that it had begun initial discussions for a settlement with the DOJ on February 11, 2025. However, those discussions ceased on the same day. As a result, the firm has raised concerns about the possibility of the DOJ pursuing a civil lawsuit under the False Claims Act, asserting that the severity of potential damages cannot be reasonably estimated.
On February 28, 2025, the company released this pivotal information, leading to a sharp decline of over 9% in their stock price during the following trading day. Given this volatility, it is becoming increasingly critical for affected investors to understand their situation and participate in the ongoing legal proceedings.
The court will appoint a lead plaintiff who holds the largest financial stake in the case, and this individual will have the responsibility of managing the litigation on behalf of the affected class members. However, it's important to note that participating as a lead plaintiff is not compulsory. Any impacted investor retains their right to recovery regardless of whether they choose to take on this active role or remain a member of the class.
Faruqi & Faruqi, LLP promotes engagement with anyone who might possess information regarding the actions of Semler Scientific. This includes former employees, whistleblowers, and shareholders who can provide insights into the company’s practices during the investigated timeframe.
For those interested in understanding more about the class action concerning Semler Scientific, the firm has created a dedicated page with comprehensive details. Interested parties are encouraged to visit it or contact Josh Wilson for personal consultations to evaluate their potential claims further.
Through its commitment to safeguarding the rights of investors, Faruqi & Faruqi aims to ensure that the facts surrounding Semler Scientific's operations are brought to light and addressed appropriately. With its long-standing history of recovering substantial sums for clients since its establishment in 1995, the firm emphasizes its dedication to providing quality legal support to its clients. Investors must act swiftly to navigate this complex legal environment effectively, ensuring they are heard and their rights are upheld.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.